The serotonergic system in Parkinson's disease

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536 · see citing works

EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,143 · see citing works

Primate models of movement disorders of basal ganglia origin

DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824 · see citing works

A review of central 5-HT receptors and their function

Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,150 · see citing works

Unified Parkinson's Disease Rating Scale

(2012) · Springer eBooks · doi:10.1007/springerreference_184495 · Cited by 3,071 · see citing works

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 2,997 · see citing works

Stages in the development of Parkinson’s disease-related pathology

Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · see citing works

An Essay on the Shaking Palsy

Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,684 · see citing works

Recent developments in Parkinson's disease

Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306 · see citing works

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161 · see citing works

The expanded biology of serotonin

Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100 · see citing works

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

Tol, H. H. M. V., Bunzow, J. R., Guan, H., Sunahara, R. K., Seeman, P. M., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,015 · see citing works

Recent Developments in Parkinson's Disease

Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,926 · see citing works

Molecular, pharmacological and functional diversity of 5-HT receptors

Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,869 · see citing works

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors

Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · see citing works

Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform

Walther, D. J., Peter, J., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., & Bäder, M. (2003) · Science · doi:10.1126/science.1078197 · Cited by 1,576 · see citing works

Aromatic amino acids and modification of parkinsonism.

Cotzias, G., van Woert, M. H., & Schiffer, L. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760703 · Cited by 1,501 · see citing works

Atlas of the Human Brain

Jeurgen, K., Assheuer, J., & Paxinos, G. (1997) · Medical Entomology and Zoology · Cited by 1,416 · see citing works

Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidium in basal ganglia circuitry

Parent, A., & Hazrati, L. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00008-d · Cited by 1,351 · see citing works

Modification of Parkinsonism — Chronic Treatment with L-Dopa

Cotzias, G. C., Papavasiliou, P. S., & Gellene, R. A. (1969) · New England Journal of Medicine · doi:10.1056/nejm196902132800701 · Cited by 1,287 · see citing works

Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors

Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., & Julius, D. J. (1995) · Nature · doi:10.1038/374542a0 · Cited by 1,275 · see citing works

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., & Saxena, P. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90207-8 · Cited by 1,259 · see citing works

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Gompel, P. V., Lesage, A. S., Loore, K. D., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167 · see citing works

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B. K., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,119 · see citing works

Circuits and Circuit Disorders of the Basal Ganglia

DeLong, M. R., & Wichmann, T. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.20 · Cited by 1,074 · see citing works

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

Leysen, J. E., Niemegeers, C. J. E., Nueten, J. M. V., & Laduron, P. M. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14623-3 · Cited by 1,071 · see citing works

The Rhesus Monkey Brain in Stereotaxic Coordinates

Paxinos, G., Huang, X., & Toga, A. W. (1999) · Research Online (University of Wollongong) · Cited by 1,070 · see citing works

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., Seeman, P. M., & Wong, D. T. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00129-n · Cited by 1,061 · see citing works

Sydney multicenter study of Parkinson's disease: Non‐<scp>L</scp>‐dopa–responsive problems dominate at 15 years

Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050 · see citing works

Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors

Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035 · see citing works

Regulation of serotonin-2C receptor G-protein coupling by RNA editing

Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010 · see citing works

Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel

Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R., & Julius, D. J. (1991) · Science · doi:10.1126/science.1718042 · Cited by 978 · see citing works

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939 · see citing works

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2000) · Synapse · doi:10.1002/1098-2396(20010101)39:1 · Cited by 934 · see citing works

The mysterious motor function of the basal ganglia

MARSDEN, C. D. (1982) · Neurology · doi:10.1212/wnl.32.5.514 · Cited by 924 · see citing works

Serotonin Receptors

Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895 · see citing works

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease

Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054830 · Cited by 882 · see citing works

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Ramamoorthy, S., Bauman, A. L., Moore, K. R., Han, H. J., Yang‐Feng, T. L., Chang, A. S., Ganapathy, V., & Blakely, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2542 · Cited by 880 · see citing works

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 870 · see citing works

8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site

Middlemiss, D. N., & Fozard, J. R. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90230-3 · Cited by 868 · see citing works

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

Kilpatrick, G. J., Jones, B. J., & Tyers, M. B. (1987) · Nature · doi:10.1038/330746a0 · Cited by 866 · see citing works

Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists

Sprouse, J. S., & Aghajanian, G. K. (1987) · Synapse · doi:10.1002/syn.890010103 · Cited by 848 · see citing works

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

Leysen, J. E., Awouters, F. H. L., Kennis, L. E. J., Laduron, P. M., Vandenberk, J., & Janssen, P. A. J. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90747-5 · Cited by 843 · see citing works

Enhanced Aggressive Behavior in Mice Lacking 5-HT 1B Receptor

Saudou, F., Amara, D. A., Dierich, A., LeMeur, M., Ramboz, S., Ségu, L., Buhot, M.-C., & Hen, R. (1994) · Science · doi:10.1126/science.8091214 · Cited by 839 · see citing works

Cloning and expression of a functional serotonin transporter from rat brain

Blakely, R., Berson, H. E., Fremeau, R. T., Caron, M. G., Peek, M. M., Prince, H. K., & Bradley, C. C. (1991) · Nature · doi:10.1038/354066a0 · Cited by 831 · see citing works

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors

Pazos, Á., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824 · see citing works

Serotonin neurons of the midbrain raphe: Ascending projections

Moore, R. Y., Halaris, A. E., & Jones, B. E. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800302 · Cited by 803 · see citing works

A Review of the Pharmacological and Clinical Profile of Mirtazapine

Anttila, S. A. K., & Leinonen, E. V. J. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00198.x · Cited by 796 · see citing works

A unique central tryptophan hydroxylase isoform

Walther, D. J., & Bäder, M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00556-2 · Cited by 752 · see citing works

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

Scatton, B., Javoy-Agid, F., Rouquier, L., Dubois, B., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90993-9 · Cited by 727 · see citing works

Evidence for Possible Involvement of 5-HT _2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722 · see citing works

Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation

Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 714 · see citing works

APPLICATION OF STEADY STATE KINETICS TO THE ESTIMATION OF SYNTHESIS RATE AND TURNOVER TIME OF TISSUE CATECHOLAMINES

Brodie, B. B., Costa, E., Dlabač, A., Neff, N. H., & Smookler, H. H. (1966) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27496-1 · Cited by 710 · see citing works

Elevated anxiety and antidepressant-like responses in serotonin 5-HT 1A receptor mutant mice

Heisler, L. K., Chu, H.-M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H., & Tecott, L. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15049 · Cited by 704 · see citing works

Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding

Pompeiano, M., Palacios, J., & Mengod, G. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00440.1992 · Cited by 699 · see citing works

Molecular Characterization of a Functional cDNA Encoding the Serotonin 1c Receptor

Julius, D. J., MacDermott, A. B., Axel, R., & Jessell, T. M. (1988) · Science · doi:10.1126/science.3399891 · Cited by 694 · see citing works

Increased anxiety of mice lacking the serotonin 1A receptor

Parks, C. L., Robinson, P. S., Sibille, E. L., Shenk, T. E., & Tóth, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10734 · Cited by 691 · see citing works

Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors

Pazos, Á., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90326-5 · Cited by 684 · see citing works

Molecular biology of 5-HT receptors

Boess, F., & Martin, I. L. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90059-0 · Cited by 675 · see citing works

Identification of Enteramine, the Specific Hormone of the Enterochromaffin Cell System, as 5-Hydroxytryptamine

Erspamer, V., & Asero, B. (1952) · Nature · doi:10.1038/169800b0 · Cited by 674 · see citing works

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease

Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664 · see citing works

The raphe nuclei of the cat brain stem: A topographical atlas of their efferent projections as revealed by autoradiography

Bobillier, P., Seguin, S., Petitjean, F., Salvert, D., Touret, M., & Jouvet, M. (1976) · Brain Research · doi:10.1016/0006-8993(76)90050-0 · Cited by 660 · see citing works

Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission

Alex, K. D., & Pehek, E. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.004 · Cited by 658 · see citing works

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

Sargent, P. A., Kjaer, K. H., Bench, C. J., Rabiner, E. A., Messa, C., Meyer, J., Gunn, R. N., Grasby, P. M., & Cowen, P. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.174 · Cited by 642 · see citing works

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

Carta, M., Carlsson, T., Kirik, D., & Björklund, A. (2007) · Brain · doi:10.1093/brain/awm082 · Cited by 637 · see citing works

Extrinsic connections of the basal ganglia

Parent, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90105-j · Cited by 633 · see citing works

5-HT3 receptors are membrane ion channels

Derkach, V. A., Surprenant, A., & NORTH, R. A. (1989) · Nature · doi:10.1038/339706a0 · Cited by 630 · see citing works

5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex

Araneda, R. C., & Andrade, R. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90128-b · Cited by 621 · see citing works

Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.

Ruat, M., Traiffort, É., Leurs, R., Tardivel‐Lacombe, J., Díaz, J., Arrang, J., & Schwartz, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8547 · Cited by 617 · see citing works

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease

The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 616 · see citing works

Binding of antipsychotic drugs to human brain receptors

Richelson, E., & Souder, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00911-5 · Cited by 608 · see citing works

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS

Woolley, D. W., & Shaw, E. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.4.228 · Cited by 603 · see citing works

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

Monsma, F. J., Shen, Y., Ward, R. P., Hamblin, M. W., & Sibley, D. R. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13616-x · Cited by 598 · see citing works

The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor

Fargin, A., Raymond, J. R., Lohse, M. J., Kobilka, B. K., Caron, M. G., & Lefkowitz, R. J. (1988) · Nature · doi:10.1038/335358a0 · Cited by 597 · see citing works

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

Choudhary, M. S., Craigo, S. C., Sibley, D. R., Roth, B. L., Monsma, F. J., Shen, Y., Uluer, A., & Meltzer, H. Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/74zp-ze10 · Cited by 592 · see citing works

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

Hyttel, J. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80179-6 · Cited by 585 · see citing works

Carpenter's Human Neuroanatomy

Parent, A., & Carpenter, M. B. (1996) · Medical Entomology and Zoology · Cited by 561 · see citing works

The 5-HT3B subunit is a major determinant of serotonin-receptor function

Davies, P. A., Pistis, M., Hanna, M. C., Peters, J. A., Lambert, J. J., Hales, T. G., & Kirkness, E. F. (1999) · Nature · doi:10.1038/16941 · Cited by 561 · see citing works

The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease

Paulus, W., & Jellinger, K. A. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 556 · see citing works

A proposed new nomenclature for 5-HT receptors

Humphrey, P. P. A., Hartig, P. R., & Hoyer, D. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90016-d · Cited by 553 · see citing works

SERUM VASOCONSTRICTOR (SEROTONIN)

Rapport, M. M., Green, A. A., & Page, I. H. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57137-4 · Cited by 552 · see citing works

5-Hydroxytryptamine _2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536 · see citing works

Serotonin Content of Some Mammalian Tissues and Urine and a Method for Its Determination

Twarog, B. M., & Page, I. H. (1953) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1953.175.1.157 · Cited by 532 · see citing works

Is there a role for 5-HT1A agonists in the treatment of depression?

Blier, P., & Ward, N. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01643-8 · Cited by 529 · see citing works

Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake

Richelson, E., & Pfenning, M. A. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90403-5 · Cited by 529 · see citing works

Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3h]5-hydroxytryptamine

Parent, A., Descarries, L., & Beaudet, A. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90050-6 · Cited by 525 · see citing works

Molecular mechanisms of L-DOPA-induced dyskinesia

Jenner, P. G. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2471 · Cited by 522 · see citing works

Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

Bézard, E., Brotchie, J., & Gross, C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 518 · see citing works

Serotonin Induces Excitatory Postsynaptic Potentials in Apical Dendrites of Neocortical Pyramidal Cells

Aghajanian, G. K., & Marek, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 516 · see citing works

An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins

Kobilka, B. K., Frielle, T., Collins, S., Yang-Feng, T. L., Kobilka, T. S., Francke, U., Lefkowitz, R. J., & Caron, M. G. (1987) · Nature · doi:10.1038/329075a0 · Cited by 515 · see citing works

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

Jordan, S., Koprivica, V., Chen, R., Tottori, K., Kikuchi, T., & Altar, C. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01532-7 · Cited by 512 · see citing works

Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain

Riad, M., Garcia, S., Watkins, K. C., Jodoin, N., Doucet, �., Langlois, X., Mestikawy, S. E., Hamon, M., & Descarries, L. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000207)417:2 · Cited by 502 · see citing works

Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens

Yoshimoto, K., McBride, W. J., Lumeng, L., & Li, T. (1992) · Alcohol · doi:10.1016/0741-8329(92)90004-t · Cited by 499 · see citing works

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)

Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · see citing works

Event-Related Potentials

Thigpen, N., & Keil, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.02456-1 · Cited by 490 · see citing works

Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): [RETIRED]

Miyasaki, J. M., Shannon, K. M., Voon, V., Ravina, B. M., Kleiner‐Fisman, G., Anderson, K., Shulman, L. M., Gronseth, G., & Weiner, W. J. (2006) · Neurology · doi:10.1212/01.wnl.0000215428.46057.3d · Cited by 488 · see citing works

Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex

Santana, N. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh070 · Cited by 486 · see citing works

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

Millan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J. A., & Newman‐Tancredi, A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039867 · Cited by 485 · see citing works

Drugs and Valvular Heart Disease

Roth, B. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068265 · Cited by 479 · see citing works

Levodopa motor complications in Parkinson's disease

Obeso, J. A., Olanow, C. W., & Nutt, J. G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00031-8 · Cited by 478 · see citing works

Levodopa‐induced dyskinesias

Fabbrini, G., Brotchie, J. M., Grandas, F., Nomoto, M., & Goetz, C. G. (2007) · Movement Disorders · doi:10.1002/mds.21475 · Cited by 465 · see citing works

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Leysen, J. E., Gommeren, W., Gompel, P. V., Wynants, J., Janssen, P. F. M., & Laduron, P. M. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12558-3 · Cited by 452 · see citing works

A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Dumuis, A., Bouhelal, R., Sebben, M., Cory, R. N., & Bockaert, J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10130-2 · Cited by 450 · see citing works

Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine

Fitzgerald, L. W., Burn, T. C., Brown, B. S., Patterson, J. P., Corjay, M. H., Valentine, P. A., Sun, J., Link, J. R., Abbaszade, I. G., Hollis, J. M., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26444-0 · Cited by 440 · see citing works

Cortical 5-HT 2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice

Weisstaub, N., Zhou, M., Lira, A., Lambe, E. K., González‐Maeso, J., Hornung, J., Sibille, E. L., Underwood, M. D., Itohara, S., Dauer, W. T., et al. (2006) · Science · doi:10.1126/science.1123432 · Cited by 425 · see citing works

Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs

Han, D. D., & Gu, H. H. (2006) · BMC Pharmacology · doi:10.1186/1471-2210-6-6 · Cited by 419 · see citing works

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

Voon, V., Hassan, K. T., Zurowski, M., de Souza, M., Thomsen, T. R., Fox, S. H., Lang, A. E., & Miyasaki, J. M. (2006) · Neurology · doi:10.1212/01.wnl.0000238503.20816.13 · Cited by 417 · see citing works

A Novel Rat Serotonin (5-HT6) Receptor: Molecular Cloning, Localization and Stimulation of cAMP Accumulation

Ruat, M., Traiffort, É., Arrang, J., Tardivel‐Lacombe, J., Díaz, J., Leurs, R., & Schwartz, J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1619 · Cited by 413 · see citing works

Biochemical profile of risperidone, a new antipsychotic.

Leysen, J. E., Gommeren, W., Eens, A., de Courcelles, D. D. C., Stoof, J. C., & Janssen, P. A. J. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13416-2 · Cited by 412 · see citing works

L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Barbeau, A. (1969) · PubMed · Cited by 409 · see citing works

Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes

Lawler, C. P. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00099-2 · Cited by 409 · see citing works

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease

Halliday, G. M., Li, Y. W., Blumbergs, P. C., JOH, T. H., Cotton, R. G. H., Howe, P. R. C., Blessing, W. W., & Geffen, L. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270405 · Cited by 409 · see citing works

5-HT Receptor Regulation of Neurotransmitter Release

Fink, K., & Göthert, M. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.07103 · Cited by 389 · see citing works

Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic study

Chalmers, D. T., & Watson, S. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90748-k · Cited by 388 · see citing works

Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor

Kohen, R., Metcalf, M. A., Khan, N. A., Druck, T., Huebner, K., Lachowicz, J. E., Meltzer, H. Y., Sibley, D. R., Roth, B. L., & Hamblin, M. W. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010047.x · Cited by 377 · see citing works

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease

Kish, S. J., Tong, J., Hornykiewicz, O., Rajput, A. H., Chang, L.-J., Guttman, M., & Furukawa, Y. (2007) · Brain · doi:10.1093/brain/awm239 · Cited by 376 · see citing works

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

Aghajanian, G. K., & Marek, G. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01224-x · Cited by 376 · see citing works

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS

Clemett, D. A., Punhani, T., Duxon, M. S., Blackburn, T. P., & Fone, K. C. F. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00086-6 · Cited by 373 · see citing works

Serotonin and hallucinogens

Aghajanian, G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00135-3 · Cited by 371 · see citing works

Co-expression and In Vivo Interaction of Serotonin1A and Serotonin2A Receptors in Pyramidal Neurons of Prefrontal Cortex

Amargos-Bosch, M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg128 · Cited by 370 · see citing works

The organization of divergent axonal projections from the midbrain raphe nuclei in the rat

Imai, H., Steindler, D. A., & Kitai, S. T. (1986) · The Journal of Comparative Neurology · doi:10.1002/cne.902430307 · Cited by 369 · see citing works

Nervous system distribution of the serotonin 5-HT3 receptor mRNA.

Tecott, L. H., Maricq, A. V., & Julius, D. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1430 · Cited by 368 · see citing works

Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease

Halliday, G. M., Blumbergs, P. C., Cotton, R. G. H., Blessing, W. W., & Geffen, L. B. (1990) · Brain Research · doi:10.1016/0006-8993(90)90733-r · Cited by 366 · see citing works

RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity

Niswender, C. M., Copeland, S. C., Herrick‐Davis, K., Emeson, R. B., & Sanders‐Bush, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9472 · Cited by 364 · see citing works

Elevated alcohol consumption in null mutant mice lacking 5–HT1B serotonin receptors

Crabbe, J. C., Phillips, T. J., Feller, D. J., Hen, R., Wenger, C. D., Lessov, C. N., & Schafer, G. L. (1996) · Nature Genetics · doi:10.1038/ng0996-98 · Cited by 360 · see citing works

Functional characterization of agonists at recombinant human 5‐HT2A, 5‐HT2B and 5‐HT2C receptors in CHO‐K1 cells

Porter, R. H. P., Benwell, K. R., Lamb, H., Malcolm, C., Allen, N. H., Revell, D. F., Adams, D. R., & Sheardown, M. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702751 · Cited by 359 · see citing works

Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.

Kehne, J. H., Baron, B. M., Carr, A. A., Chaney, S., Elands, J., Feldman, D. J., Frank, R. A., van Giersbergen, P. L. M., McCloskey, T. C., Johnson, M., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12956-x · Cited by 359 · see citing works

Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

Costall, B., Domeney, A. M., Naylor, R. J., et al. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11394.x · Cited by 356 · see citing works

Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors

Pazos, A., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90327-7 · Cited by 355 · see citing works

The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals

Boschert, U., Amara, D. A., Ségu, L., & Hen, R. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90164-3 · Cited by 352 · see citing works

Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain

Bruinvels, A. T., Landwehrmeyer, G. B., Gustafson, E. L., Durkin, M. M., Mengod, G., Branchek, T. A., Hoyer, D., & Palacios, J. M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90067-1 · Cited by 350 · see citing works

Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's Disease

Andersson, M., Hilbertson, A., & Cenci, M. A. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0259 · Cited by 350 · see citing works

The history of dopamine and levodopa in the treatment of Parkinson's disease

Fahn, S. (2008) · Movement Disorders · doi:10.1002/mds.22028 · Cited by 344 · see citing works

Altered serotonin metabolism in depressed patients with Parkinson's disease

Mayeux, R. P., Stern, Y., COTE, L. J., & Williams, J. B. W. (1984) · Neurology · doi:10.1212/wnl.34.5.642 · Cited by 343 · see citing works

The pathogenesis of Parkinson's disease: a new hypothesis.

Barbeau, A. (1962) · PubMed · Cited by 340 · see citing works

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

Nordström, A., Farde, L., Nyberg, S., Karlsson, P., Halldin, C., & Sedvall, G. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.10.1444 · Cited by 339 · see citing works

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction

Pavese, N., Metta, V., Bose, S. K., Chaudhuri, К. R., & Brooks, D. J. (2010) · Brain · doi:10.1093/brain/awq268 · Cited by 335 · see citing works

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: A comparative study with dorsal raphe neurons

Sprouse, J. S., & Aghajanian, G. K. (1988) · Neuropharmacology · doi:10.1016/0028-3908(88)90079-2 · Cited by 333 · see citing works

Serotonin receptors: from protein to physiological function and behavior

Sari, Y. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.08.008 · Cited by 332 · see citing works

Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up

Pollak, P. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029868 · Cited by 332 · see citing works

Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.

Varnäs, K., Halldin, C., & Hall, H. (2004) · Human Brain Mapping · doi:10.1002/hbm.20035 · Cited by 332 · see citing works

The pharmacologic profile of mirtazapine.

de Boer, T. (1996) · PubMed · Cited by 330 · see citing works

Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system

Gérard, C., Martres, M., Lefèvre, K., Miquel, M., Vergé, D., Lanfumey, L., Doucet, E., Hamon, M., & Mestikawy, S. E. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01224-3 · Cited by 327 · see citing works

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Seeger, T., Seymour, P. A., Schmidt, A. W., Zorn, S. H., Schulz, D. W., Lebel, L. A., McLean, S., Guanowsky, V., Howard, H. R., & Lowe, J. A., III (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12023-5 · Cited by 322 · see citing works

Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease

Camp, G. V., Flamez, A., Cosyns, B., Weytjens, C., Muyldermans, L., Zandijcke, M. V., SUTTER, J. D., Santens, P., Decoodt, P., Moerman, C., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15945-x · Cited by 320 · see citing works

Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants

Politis, M., Wu, K., Loane, C., Quinn, N. P., Brooks, D. J., Rehncrona, S., Björklund, A., Lindvall, O., & Piccini, P. P. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000976 · Cited by 318 · see citing works

Organization of the basal ganglia: the importance of axonal collateralization

Parent, A., Sato, F., Wu, Y. N., Gauthier, J., Lévesque, M., & Parent, M. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00022-7 · Cited by 306 · see citing works

3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro

Setola, V., Hufeisen, S. J., Grande-Allen, K. J., Veselý, I., Glennon, R. A., Blough, B. E., Rothman, R. B., & Roth, B. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1223 · Cited by 305 · see citing works

Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors

Müller, C. P., Carey, R. J., Huston, J. P., & Silva, M. A. D. S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.001 · Cited by 302 · see citing works

Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats

Tanaka, H., Kannari, K., Maeda, T., Tomiyama, M., Suda, T., & Matsunaga, M. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00034 · Cited by 302 · see citing works

Tremor in Parkinson’s disease and serotonergic dysfunction

Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J., & Brooks, D. J. (2003) · Neurology · doi:10.1212/01.wnl.0000031424.51127.2b · Cited by 302 · see citing works

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

Battaglia, G., Brooks, B. P., Kulsakdinun, C., & Souza, E. B. D. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90056-8 · Cited by 301 · see citing works

Double‐blind, placebo‐controlled, unforced titration parallel trial of quetiapine for dopaminergic‐induced hallucinations in Parkinson's disease

Ondo, W. G., Tintner, R., Voung, K. D., Lai, D., & Ringholz, G. M. (2005) · Movement Disorders · doi:10.1002/mds.20474 · Cited by 297 · see citing works

Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.

Breese, G. R., Baumeister, A., McCown, T. J., et al. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21630-5 · Cited by 296 · see citing works

Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta.

Weinshank, R. L., Zgombick, J. M., Macchi, M., Branchek, T. A., & Hartig, P. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3630 · Cited by 294 · see citing works

Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis

Meltzer, H. Y., Mills, R., Revell, S., Williams, H., Johnson, A. D., Bahr, D., & Friedman, J. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.176 · Cited by 293 · see citing works

Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites

Hoyer, D., Pazos, Á., Probst, A., & Palacios, J. M. (1986) · Brain Research · doi:10.1016/0006-8993(86)90903-0 · Cited by 291 · see citing works

Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model

Diederich, N. J., Goetz, C. G., & Stebbins, G. T. (2004) · Movement Disorders · doi:10.1002/mds.20308 · Cited by 290 · see citing works

Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder

Picchietti, D. L., Underwood, D. J., Farris, W. A., Walters, A. S., Shah, M., Dahl, R. E., Trubnick, L. J., Bertocci, M. A., Wagner, M., & Hening, W. A. (1999) · Movement Disorders · doi:10.1002/1531-8257(199911)14:6 · Cited by 289 · see citing works

SERUM VASOCONSTRICTOR (SEROTONIN)

Rapport, M. M. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51208-x · Cited by 288 · see citing works

Involvement of 5-HT1AReceptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action

Díaz-Mataix, L., Scorza, M. C., Bortolozzi, A. A., Tóth, M., Celada, P., & Artigas, F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2999-05.2005 · Cited by 288 · see citing works

5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia

Burnet, P. W. J. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00053-x · Cited by 286 · see citing works

Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.

Kapur, S., & Seeman, P. M. (2000) · PubMed · Cited by 285 · see citing works

Evidence for the existence of a raphe projection to the substantia nigra in rat

Dray, A., Gonye, T. J., Oakley, N. R., & Tanner, T. (1976) · Brain Research · doi:10.1016/0006-8993(76)90005-6 · Cited by 284 · see citing works

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

Millan, M. J., Dekeyne, A., & Gobert, A. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00078-1 · Cited by 283 · see citing works

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain

Burnet, P. W. J., Eastwood, S. L., Lacey, K., & Harrison, P. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00104-x · Cited by 283 · see citing works

Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635

Hall, H., Lundkvist, C., Halldin, C., Farde, L., Pike, V. W., McCarron, J. A., Fletcher, A., Cliffe, I. A., Barf, T. A., Wikström, H., et al. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01131-6 · Cited by 280 · see citing works

Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes

Hartig, P. R., Hoyer, D., Humphrey, P. P. A., & Martin, G. R. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)30002-3 · Cited by 280 · see citing works

Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity

Taylor, T. N., Caudle, W. M., Shepherd, K. R., Noorian, A. R., Jackson, C. R., Iuvone, P. M., Weinshenker, D., Greene, J. G., & Miller, G. W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1495-09.2009 · Cited by 278 · see citing works

Crystalline Serotonin

Rapport, M. M., Green, A. A., & Page, I. H. (1948) · Science · doi:10.1126/science.108.2804.329 · Cited by 276 · see citing works

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

Ugedo, L., Grenhoff, J., & Svensson, T. H. (1989) · Psychopharmacology · doi:10.1007/bf00442004 · Cited by 267 · see citing works

Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease

Ballanger, B., Strafella, A. P., van Eimeren, T., Zurowski, M., Rusjan, P. M., Houle, S., & Fox, S. H. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.35 · Cited by 266 · see citing works

l‐DOPA‐induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of dyskinesia

Lindgren, H. S., Andersson, D. R., Lagerkvist, S., Nissbrandt, H., & Cenci, M. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06556.x · Cited by 264 · see citing works

Motor effects of serotonin in the central nervous system

Gerson, S. C., & Baldessarini, R. J. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90368-9 · Cited by 263 · see citing works

Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia

Ottosson, D. R., Parent, M., O’Sullivan, S. S., Doveró, S., Lees, A. J., Bézard, E., Descarries, L., & Cenci, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.22097 · Cited by 262 · see citing works

Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial

Goetz, C. G., Damier, P., Hicking, C., LASKA, E. M., Müller, T. H., Olanow, C. W., Rascol, O., & Russ, H. (2006) · Movement Disorders · doi:10.1002/mds.21226 · Cited by 260 · see citing works

Effect of quetiapine in psychotic Parkinson's disease patients: A double‐blind labeled study of 3 months' duration

Rabey, J. M., Prokhorov, T., Miniovitz, A., Dobronevsky, E., & Klein, C. (2006) · Movement Disorders · doi:10.1002/mds.21116 · Cited by 259 · see citing works

The 5-HT3receptor as a therapeutic target

Thompson, A. J., & Lummis, S. C. R. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.4.527 · Cited by 258 · see citing works

Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis

Parsons, L. H., & Justice, J. B. (1993) · Brain Research · doi:10.1016/0006-8993(93)90984-u · Cited by 253 · see citing works

RS-102221: A Novel High Affinity and Selective, 5-HT 2C Receptor Antagonist

Bonhaus, D. W., Weinhardt, K. K., Taylor, M., DeSouza, A., McNeeley, P. M., Szczepanski, K., Fontana, D., Trinh, J. V., Rocha, C., Dawson, M. W., et al. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00049-x · Cited by 253 · see citing works

Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E

Niesler, B., Frank, B., Kapeller, J., & Rappold, G. (2003) · Gene · doi:10.1016/s0378-1119(03)00503-1 · Cited by 252 · see citing works

Neurotransmitter receptor alterations in Parkinson's disease

Reisine, T., Fields, J. Z., Yamamura, H. I., Bird, E. D., SPOKES, E. G. S., Schreiner, P. S., & Enna, S. J. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90514-8 · Cited by 252 · see citing works

Olanzapine and clozapine

Goetz, C. G., Blasucci, L. M., Leurgans, S. E., & Pappert, E. J. (2000) · Neurology · doi:10.1212/wnl.55.6.789 · Cited by 249 · see citing works

Aminergic systems in Alzheimer's disease and Parkinson's disease

D’Amato, R. J., Zweig, R. M., Whitehouse, P. J., Wenk, G. L., Singer, H. S., Mayeux, R. P., Price, D. L., & Snyder, S. H. (1987) · Annals of Neurology · doi:10.1002/ana.410220207 · Cited by 248 · see citing works

Clozapine-induced weight gain: prevalence and clinical relevance

Leadbetter, R. A., Shutty, M. S., Pavalonis, D., Vieweg, V., Higgins, P., & Downs, M. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.68 · Cited by 248 · see citing works

Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera

Abramowski, D., Rigo, M., Duc, D., Hoyer, D., & Staufenbiel, M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00138-7 · Cited by 243 · see citing works

Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: A fluorescent retrograde double labeling study in the rat

van der Kooy, D., & Hattori, T. (1980) · Brain Research · doi:10.1016/0006-8993(80)90250-4 · Cited by 243 · see citing works

Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca.

Hillarp, N. ‐., Fuxé, K., & Dahlström, A. B. (1966) · PubMed · Cited by 242 · see citing works

Occurrence and Localization of Catechol Amines in the Human Brain

Bertler, Å. (1961) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1961.tb02118.x · Cited by 242 · see citing works

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

Politis, M., Wu, K., Loane, C., Kiferle, L., Molloy, S., Brooks, D. J., & Piccini, P. P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.028 · Cited by 242 · see citing works

Atlas of the distribution of monoamine‐containing nerve cell bodies in the brain stem of the cat

Poitras, D., & Parent, A. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901790402 · Cited by 242 · see citing works

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Bibbiani, F., Oh, J. D., & Chase, T. N. (2001) · Neurology · doi:10.1212/wnl.57.10.1829 · Cited by 241 · see citing works

Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia

Muñoz, A., Li, Q., Gardoni, F., Marcello, E. E., Qin, C., Carlsson, T., Kirik, D., Luca, M. D., Björklund, A., Bézard, E., et al. (2008) · Brain · doi:10.1093/brain/awn235 · Cited by 241 · see citing works

15th annual meeting of the society for neuroscience

(1985) · Peptides · doi:10.1016/0196-9781(85)90125-1 · Cited by 240 · see citing works

Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites

Mengod, G., Pompeiano, M., ́nez-Mir, M. I. M., & Palacios, J. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90502-3 · Cited by 240 · see citing works

Insights into the Neurobiology of Impulsive Behavior from Serotonin Receptor Knockout Mice

Brunner, D., & Hen, R. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52356.x · Cited by 240 · see citing works

Subregional organization of preoptic area /anterior hypothalamic projections to arousal-related monoaminergic cell groups

Steininger, T. L., Gong, H., McGinty, D., & Szymusiak, R. S. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20010122)429:4 · Cited by 240 · see citing works

Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom

Bernheimer, H., Birkmayer, W., & Hornykiewicz, O. (1961) · Journal of Molecular Medicine · doi:10.1007/bf01487648 · Cited by 240 · see citing works

In vitroandin vivoprofile of SB 206553, a potent 5‐HT2C/5‐HT2Breceptor antagonist with anxiolytic‐like properties

Kennett, G. A., Wood, M. D., Bright, F., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15208.x · Cited by 240 · see citing works

A whole-brain atlas of inputs to serotonergic neurons of the dorsal and median raphe nuclei

Pollak Dorocic, I., Fürth, D., Xuan, Y., Johansson, Y., Pozzi, L., Silberberg, G., Carlén, M., & Meletis, K. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.002 · Cited by 451 · see citing works

Molecular and anatomical organization of the dorsal raphe nucleus

Huang, K. W., Ochandarena, N. E., Philson, A. C., Hyun, M., Birnbaum, J. E., Cicconet, M., & Sabatini, B. L. (2019) · eLife · doi:10.7554/elife.46464 · Cited by 267 · see citing works

Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?

Blesa, J., Foffani, G., Dehay, B., Bezard, E., & Obeso, J. A. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00542-9 · Cited by 232 · see citing works

Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms

Tong, Q., Zhang, L., Yuan, Y., Jiang, S., Zhang, R., Xu, Q., Ding, J., Li, D., Zhou, X., & Zhang, K. (2015) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2015.05.016 · Cited by 81 · see citing works

[Analysis of the interaction of the dopaminergic and serotoninergic systems in immunomodulation].

Devoino, L. V., & Лазаревна, А. Е. (1984) · PubMed

Dopaminergic and Serotonergic Drug Use: A Nationwide Register-Based Study of Over 1 300 000 Older People

Johnell, K., & Fischer, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023750 · Cited by 1 · see citing works

The interaction between the dopaminergic and the serotonergic systems in the 6-OHDA rat model of Parkinson’s disease

Sourani, D., & Goelman, G. (2012) · Health · doi:10.4236/health.2012.431179 · Cited by 1 · see citing works

Trophic Effects of Striatal Proteins on Central Dopaminergic Neurons in Culture

Valdes, H. B., Nonner, D., Rulli, D., Gralnik, L. M., & Barrett, J. N. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0759-4_20 · Cited by 3 · see citing works

Interaction of the dopaminergic and serotonergic systems in the rat striatum: effects of selective antagonists and uptake inhibitors

P., T. (1995) · Neuroscience Research · doi:10.1016/0168-0102(95)00934-l · Cited by 5 · see citing works